Endonovo Therapeutics Inc (ENDV)

[John_Vallay]

Endonovo PAYS for their appearance on NEW TO THE STREET.

It's paid advertising.

NEW TO THE STREET in turn pays Newsmax, Fox Business Network and Bloomberg to air their client interviews.

Endonovo is using shareholder money to pay for advertising which will not yield any ROI for the sale of products or stock promoting.

for the first quarter of 2023 Endonovo had $87,540 in sales. That is not only NOT EVEN CLOSE to the so-called revenue projections or even respectful.
$87,540 is an embarrassment and a joke.

I think people have caught on because only 45,304 shares traded today. That is basically zero and what it shows is that the company cannot raise any further capital because the people that give convertible notes are not going to give any more money to endonovo.